SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 21st, 2025 • Luminar Technologies, Inc./De • Motor vehicle parts & accessories • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 19, 2025, is by and among Luminar Technologies, Inc., a Delaware corporation (the “Company”), and each of the investors signatory hereto (individually, a “Buyer” and collectively, the “Buyers”). Capitalized terms used in this Agreement without definition have the respective meanings ascribed to them in the Certificate of Designations (as defined below).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 26th, 2025 • Innventure, Inc. • Blank checks
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 25, 2025, is between INNVENTURE, INC., a company incorporated under the laws of the State of Delaware (the “Company”), and each of the investors listed on the Schedule of Buyers attached as Schedule I hereto (individually, a “Buyer” and collectively the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 13th, 2021 • American Virtual Cloud Technologies, Inc. • Services-computer integrated systems design • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of December 13, 2021, is by and among American Virtual Cloud Technologies, Inc., a Delaware corporation with headquarters located at 1720 Peachtree Street, Suite 629, Atlanta, GA 30309 (the “Company”), and the investor listed on the Schedule of Buyers attached hereto the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 21st, 2018 • Broadfin Capital, LLC • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of May 17, 2018, is by and among Biodelivery Sciences International, Inc., a Delaware corporation with headquarters located 4131 ParkLake Ave., Suite 225, Raleigh, North Carolina 27612, (the “Company”), and each of the investors listed on Schedule 1 hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 17th, 2018 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of May 17, 2018, is by and among Biodelivery Sciences International, Inc., a Delaware corporation with headquarters located 4131 ParkLake Ave., Suite 225, Raleigh, North Carolina 27612, (the “Company”), and each of the investors listed on Schedule 1 hereto (individually, a “Buyer” and collectively, the “Buyers”).